Clinical Trial Update: Exploratory Metabolomics Study of Exhaled Breath in Pulmonary Embolism

View source ↗

Summary

This entry reports that a clinical trial investigating exploratory metabolomics of exhaled breath in pulmonary embolism has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Pulmonary Embolism | Status: TERMINATED